miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells

Drug resistance remains a major problem in the treatment of conventional chemotherapeutic agents in breast cancers. Owing to heterogeneity and complexity of chemoresistance mechanisms, most efforts that focus on a single pathway were unsuccessful, and exploring novel personalized therapeutics become...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Danni, Si, Wengong, Shen, Jiaying, Du, Chengyong, Lou, Weiyang, Bao, Chang, Zheng, Huilin, Pan, Jie, Zhong, Guansheng, Xu, Liang, Fu, Peifen, Fan, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833695/
https://www.ncbi.nlm.nih.gov/pubmed/29416005
http://dx.doi.org/10.1038/s41419-017-0211-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833695/
https://www.ncbi.nlm.nih.gov/pubmed/29416005
http://dx.doi.org/10.1038/s41419-017-0211-4

Ejemplares similares